CORC

在结果中检索

CORC

浏览/检索结果: 共66条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Application of X-ray diffraction and energy dispersive spectroscopy in the isolation of sulfated polysaccharide from Porphyra haitanensis and its antioxidant capacity under in vitro digestion 期刊论文
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2021, 页码: 11
作者:  Chen, Peilin;  Xu, Yanhong;  Yang, Shuqi;  Chang, Qing;  Zheng, Baodong
收藏  |  浏览/下载：171/0  |  提交时间：2021/06/22
Broad-scale distribution of diazotrophic communities is driven more by aridity index and temperature than by soil properties across various forests 期刊论文
GLOBAL ECOLOGY AND BIOGEOGRAPHY, 2020, 页码: DOI: 10.1111/geb.13178
作者:  Zhao Wenqiang;  Kou Yongping;  Wang Xiaohu;  Wu Yanhong;  Bing Haijian
收藏  |  浏览/下载：64/0  |  提交时间：2020/10/23
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：58/0  |  提交时间：2019/12/05
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1
作者:  Wu, Chunyan;  Shao, Zhimin;  Xu, Binghe;  Zhang, Qingyuan;  Xu, Ruihua
收藏  |  浏览/下载：123/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Presence of recombination hotspots throughout SLC6A3 期刊论文
PLOS ONE, 2019, 卷号: 14, 期号: 6, 页码: e0218129
作者:  Zhao, Juan;  Zhou, Yanhong;  Xiong, Nian;  Qing, Hong;  Wang, Tao
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/03
The impact of the national action plan on the epidemiology of antibiotic resistance among 352,238 isolates in a teaching hospital in China from 2015 to 2018 期刊论文
Antimicrobial resistance and infection control, 2019, 卷号: 8, 页码: 22
作者:  Wang Shanjuan[1];  Hu Yanhong Jessika[2];  Little Paul[3];  Wang Yifei[4];  Chang Qing[5]
收藏  |  浏览/下载：11/0  |  提交时间：2019/04/22
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace